Security National Bank’s GSK GSK Stock Holding History

Security National Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Hold	2,359	–	–	0.01%	182
2026 Q1	$130K	Hold	2,359	–	–	0.02%	169
2025 Q4	$116K	Hold	2,359	–	–	0.02%	172
2025 Q3	$102K	Hold	2,359	–	–	0.02%	187
2025 Q2	$90.6K	Buy	2,359 +106	+5%	+$4.05K	0.02%	176
2025 Q1	$87.3K	Buy	2,253 +50	+2%	+$1.83K	0.02%	172
2024 Q4	$74.5K	Hold	2,203	–	–	0.01%	177
2024 Q3	$90.1K	Hold	2,203	–	–	0.01%	156
2024 Q2	$84.8K	Hold	2,203	–	–	0.01%	155
2024 Q1	$94.4K	Hold	2,203	–	–	0.01%	148
2023 Q4	$81.6K	Buy	+2,203	New	+$79.1K	0.02%	164
2022 Q3	–	Sell	-4,576	Closed	-$249K	–	101
2022 Q2	$249K	Buy	4,576 +179	+4%	+$9.88K	0.07%	86
2022 Q1	$239K	Hold	4,397	–	–	0.05%	96
2021 Q4	$242K	Buy	+4,397	New	+$229K	0.05%	95

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Security National Bank's GSK Position: Q2 2026 in Review

Security National Bank held its GSK (GSK) position steady in Q2 2026 at 2,359 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #182.

Security National Bank first reported a position in GSK in Q4 2021 and has held it in 14 quarters since. The position peaked at $249K in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Security National Bank held 2,359 shares of GSK worth $124K as of Q2 2026.
Security National Bank left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Security National Bank's portfolio in Q2 2026, its #182 holding.
Security National Bank first reported a position in GSK in Q4 2021 and has held it in 14 quarters since.
Security National Bank's GSK position peaked at $249K in Q2 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.